We've gathered perspectives shared through our Oliver Wyman Health innovation community into easy-to-share compendiums – collections of concise but detailed information on the most top-of-mind strategic considerations facing today's incumbents and new entrants alike.
It's critical that legacy organizations begin the hard work of examining their value promise. The innovators aren’t sitting around waiting, and consumers won’t either.Terry Stone, Managing Partner, Health & Life Sciences
